Home » Topics » Regulatory

Regulatory
RSS

FDA approval for Invanz

Dec. 22, 2006

Pediatric indication approved for Colazal

Dec. 22, 2006

FDA approval for Bio-E-Gel, to be marketed as Elestrin

Dec. 19, 2006

MuGard receives FDA approval

Dec. 14, 2006

Abilify Injection now available

Dec. 14, 2006

Velcade approved for relapsed mantle cell lymphoma

Dec. 12, 2006

Humira receives approval for expanded indication in psoriatic arthritis

Nov. 15, 2006

FDA approval for Polyphenon E Ointment

Nov. 2, 2006

Japanese approval for Sonazoid ultrasound contrast medium

Oct. 27, 2006

Noxafil approved for treatment of oropharyngeal candidiasis

Oct. 25, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.